| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Counted by filing, the last 12 months brought 4 open-market purchases by 2 insiders worth about $26K and 23 sales by 4 insiders worth about $4.6M. The 12 months before that brought 6 open-market purchases by 4 insiders worth about $52K and 5 sales by 3 insiders worth about $242K.
Funds and other entities also made 3 sales worth about $1.3M in the last 12 months, not counted above.
All 23 sales in the last 12 months were made under a Rule 10b5-1 trading plan set up in advance.
The largest open-market purchase in the last two years was 5,500 shares by Kevin D Freeman (Director) at an average $3.55 on December 23, 2025, about $20K. Three months later GALT was down 28%.
The most recent purchase was by Kary Eldred (Director) on February 6, 2026.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 44.71M | $149.79M | - | |
| 10% | 5.61M | $18.81M | - | |
| CEO | 832.6K | $2.79M | - | |
| Dir | 65.7K | $220.0K | - | |
| Dir | 55.3K | $185.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Khurram Jamil | Chief Medical Officer | Sale+OE10b5-1 | 16,250 | $5.13 | $83,284.50 | - | -27.5% | - | |
| Jun 29, 2026 | Harold H. Shlevin93 | Director | Sale+OE10b5-1 | 30,000 | $5.03 | $150,890.72 | -82.2% | -20.9% | - | |
| Jun 29, 2026 | Khurram Jamil | Chief Medical Officer | Sale+OE10b5-1 | 52,037 | $5.04 | $262,083.68 | - | -20.9% | - | |
| Jun 23, 2026 | Khurram Jamil | Chief Medical Officer | Sale+OE10b5-1 | 7,557 | $3.14 | $23,728.98 | - | +26.9% | - | |
| May 26, 2026 | Khurram Jamil | Chief Medical Officer | Sale+OE10b5-1 | 568 | $3.10 | $1,761.03 | - | +39.1% | - | |
| Feb 6, 2026 | Kary Eldred81 | Director | Buy | 300 | $2.70 | $810.00 | +0.5% | -24.6% | - | |
| Jan 6, 2026 | Joel Lewis67 | President and CEO | Sale+OE10b5-1 | 84,000 | $3.82 | $321,134.30 | -9.2% | -25.8% | - | |
| Jan 6, 2026 | Khurram Jamil | Chief Medical Officer | Sale+OE10b5-1 | 60,000 | $3.87 | $232,402.06 | - | -25.8% | - | |
| Jan 6, 2026 | Jack W Callicutt71 | Chief Financial Officer | Sale+OE10b5-1 | 60,000 | $3.89 | $233,387.57 | -88.7% | -25.8% | - | |
| Dec 31, 2025 | Khurram Jamil | Chief Medical Officer | Sale+OE10b5-1 | 8,125 | $4.07 | $33,089.06 | - | -32.9% | - |